On Tuesday, Shares of Aeterna Zentaris Inc. (NASDAQ:AEZS), gained 5.95% to $0.17, hitting its lowest level.
Aeterna Zentaris declared that the independent Data and Safety Monitoring Board (“DSMB”) for the pivotal Phase 3 ZoptEC (Zoptarelin Doxorubicin in Endometrial Cancer) study with zoptarelin doxorubicin in women with advanced, recurrent or metastatic endometrial cancer, will complete a pre-specified second interim efficacy and safety analysis of the compound in early October 2015.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health.
Shares of Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH), declined -3.32% to $59.38, during its last trading session.
Norwegian Cruise Line Holdings declared the pricing of the formerly declared secondary public offering of 20 million of its ordinary shares by certain funds associated with Apollo Global Administration, LLC, Star NCLC Holdings Ltd. and certain funds associated with TPG Global, LLC following an automatic shelf registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission (the “SEC”) at a price to the public of $59.25 per ordinary share. The offering is predictable to close on or about August 13, 2015, subject to customary closing conditions.
Norwegian did not sell any ordinary shares in the offering and will not receive any of the proceeds from the offering. The total number of Norwegian ordinary shares outstanding will not change as a result of the offering.
Goldman, Sachs & Co. is acting as the sole underwriter for the offering.
Norwegian Cruise Line Holdings Ltd., a cruise line operator, through its auxiliaries, provides cruise experiences for travelers with various itineraries. It offers cruises ranging from 1 day to 180 days.
Finally, Citizens Financial Group, Inc. (NYSE:CFG), ended its last trade with -1.29% loss, and closed at $26.84.
Citizens Financial Group declared the closing of its offering of $250 million aggregate principal amount of its 4.350% Subordinated Notes due 2025.
The net proceeds of the Offering were used to fund the repurchase of about 9.62 million shares of CFG’s common stock from a partner of The Royal Bank of Scotland Group plc (“RBS”) at a price of $26.00 per share which equaled the price to the public under RBS’s underwritten public offering of CFG common shares which closed yesterday. The Offering closed on July 31, 2015, and the share repurchase closed yesterday.
Right away following completion of the share repurchase transaction, RBS’s remaining ownership stake in CFG’s outstanding common shares was about 20.9%. The Offering and share repurchase transaction are part of CFG’s capital action plan as reviewed by the Federal Reserve Board in its 2015 Comprehensive Capital Analysis and Review process.
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, N.A. and Citizens Bank of Pennsylvania that provide retail and commercial banking products and services in the United States. It operates through two segments, Consumer Banking and Commercial Banking.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
